Exxelia Micropen Highlights Electrode Printing at TCT Conference
News related to:Exxelia Micropen · 2 min read
ROCHESTER, NY, UNITED STATES, October 22, 2026 /CourierPR/ -- Exxelia Micropen, a company with over 30 years of experience in precision printed electronics, is set to showcase its advanced electrode printing capabilities at the 2026 Transcatheter Cardiovascular Therapeutics (TCT) Conference in San Diego. The event, which focuses on the latest advancements in transcatheter cardiovascular therapeutics, will provide a platform for medical device manufacturers to discuss and explore new technologies for cardiac ablation.
Exxelia Micropen specializes in printing fine-line conductive traces, electrodes, sensors, and radiopaque markers onto complex, three-dimensional substrates, including catheters and balloons. These features can be as small as 50 microns in width, enabling medical device developers to incorporate intricate conductive designs directly onto their devices. This direct printing technology offers significant advantages, such as enabling controlled energy delivery and supporting the development of lower-profile catheter designs.
The company's expertise in RF ablation, denervation, nerve sensing, and electromyography (EMG) electrodes has positioned it as a valuable resource for medical device manufacturers. Exxelia Micropen has supported the development of customized RF electrode arrays, allowing researchers to evaluate thermal energy distribution during ablation. The company is also partnering with customers to apply its precision printing capabilities to pulsed field ablation (PFA) device development, a new and emerging technology in the field of cardiac ablation.
Exxelia Micropen supports customers from early-stage design and prototyping through validation, production, and testing. The company can also manage supply chain logistics for OEMs seeking to outsource a complete sub-assembly. Its customers range from emerging medical device companies to some of the world's largest manufacturers, with early engagement helping teams evaluate manufacturability, refine designs, and prepare for scalable production.
For more insight on Micropen's medical printing capabilities, visit exxelia.com/en/micropen.
Exxelia Micropen supports customers from early-stage design and prototyping through validation, production, and testing. The company can also manage supply chain logistics for OEMs seeking to outsource a complete sub-assembly. Its customers range from emerging medical device companies to some of the world's largest manufacturers, with early engagement helping teams evaluate manufacturability, refine designs, and prepare for scalable production.
For more insight on Micropen's medical printing capabilities, visit exxelia.com/en/micropen.
Exxelia Micropen supports customers from early-stage design and prototyping through validation, production, and testing. The company can also manage supply chain logistics for OEMs seeking to outsource a complete sub-assembly. Its customers range from emerging medical device companies to some of the world's largest manufacturers, with early engagement helping teams evaluate manufacturability, refine designs, and prepare for scalable production.
For more insight on Micropen's medical printing capabilities, visit exxelia.com/en/micropen.